ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/05/22 | 2,105 | 2,119 | 2,086 | 2,114 | -5 | -0.2% | 63,900 |
2025/05/21 | 2,133 | 2,140 | 2,114 | 2,119 | -6 | -0.3% | 50,300 |
2025/05/20 | 2,167 | 2,167 | 2,125 | 2,125 | -21 | -1% | 49,000 |
2025/05/19 | 2,125 | 2,149 | 2,122 | 2,146 | +6 | +0.3% | 66,100 |
2025/05/16 | 2,124 | 2,154 | 2,120 | 2,140 | +9 | +0.4% | 48,500 |
2025/05/15 | 2,128 | 2,136 | 2,120 | 2,131 | -17 | -0.8% | 47,500 |
2025/05/14 | 2,174 | 2,174 | 2,121 | 2,148 | -16 | -0.7% | 63,300 |
2025/05/13 | 2,204 | 2,210 | 2,150 | 2,164 | -8 | -0.4% | 79,500 |
2025/05/12 | 2,175 | 2,194 | 2,140 | 2,172 | -4 | -0.2% | 122,300 |
2025/05/09 | 2,229 | 2,268 | 2,176 | 2,176 | -153 | -6.6% | 323,400 |
2025/05/08 | 2,360 | 2,367 | 2,301 | 2,329 | -9 | -0.4% | 78,300 |
2025/05/07 | 2,329 | 2,343 | 2,311 | 2,338 | -5 | -0.2% | 44,300 |
2025/05/02 | 2,342 | 2,357 | 2,322 | 2,343 | -6 | -0.3% | 84,900 |
2025/05/01 | 2,343 | 2,378 | 2,332 | 2,349 | +9 | +0.4% | 55,300 |
2025/04/30 | 2,300 | 2,345 | 2,299 | 2,340 | +37 | +1.6% | 57,200 |
2025/04/28 | 2,310 | 2,327 | 2,292 | 2,303 | -7 | -0.3% | 52,400 |
2025/04/25 | 2,340 | 2,345 | 2,302 | 2,310 | -15 | -0.6% | 33,200 |
2025/04/24 | 2,346 | 2,346 | 2,313 | 2,325 | -17 | -0.7% | 32,200 |
2025/04/23 | 2,339 | 2,351 | 2,333 | 2,342 | +8 | +0.3% | 56,300 |
2025/04/22 | 2,315 | 2,337 | 2,297 | 2,334 | +22 | +1% | 38,500 |
2025/04/21 | 2,299 | 2,315 | 2,284 | 2,312 | +8 | +0.3% | 30,000 |
2025/04/18 | 2,279 | 2,309 | 2,271 | 2,304 | +52 | +2.3% | 47,800 |
2025/04/17 | 2,263 | 2,266 | 2,239 | 2,252 | -12 | -0.5% | 28,600 |
2025/04/16 | 2,233 | 2,264 | 2,227 | 2,264 | +31 | +1.4% | 37,500 |
2025/04/15 | 2,255 | 2,260 | 2,222 | 2,233 | -14 | -0.6% | 43,200 |
2025/04/14 | 2,228 | 2,255 | 2,214 | 2,247 | +63 | +2.9% | 45,000 |
2025/04/11 | 2,205 | 2,213 | 2,160 | 2,184 | -58 | -2.6% | 69,500 |
2025/04/10 | 2,233 | 2,249 | 2,188 | 2,242 | +109 | +5.1% | 84,400 |
2025/04/09 | 2,192 | 2,192 | 2,115 | 2,133 | -63 | -2.9% | 100,500 |
2025/04/08 | 2,151 | 2,200 | 2,122 | 2,196 | +59 | +2.8% | 86,600 |
2025/04/07 | 2,079 | 2,162 | 2,065 | 2,137 | -92 | -4.1% | 92,500 |
2025/04/04 | 2,279 | 2,279 | 2,194 | 2,229 | -40 | -1.8% | 89,600 |
2025/04/03 | 2,223 | 2,269 | 2,220 | 2,269 | +11 | +0.5% | 87,300 |
2025/04/02 | 2,279 | 2,294 | 2,249 | 2,258 | -39 | -1.7% | 55,100 |
2025/04/01 | 2,262 | 2,325 | 2,262 | 2,297 | +40 | +1.8% | 87,900 |
2025/03/31 | 2,281 | 2,292 | 2,249 | 2,257 | -59 | -2.5% | 106,500 |
2025/03/28 | 2,341 | 2,341 | 2,310 | 2,316 | -30 | -1.3% | 118,000 |
2025/03/27 | 2,295 | 2,374 | 2,288 | 2,346 | +28 | +1.2% | 212,300 |
2025/03/26 | 2,319 | 2,342 | 2,306 | 2,318 | +12 | +0.5% | 121,500 |
2025/03/25 | 2,317 | 2,317 | 2,263 | 2,306 | +6 | +0.3% | 64,100 |
2025/03/24 | 2,313 | 2,319 | 2,277 | 2,300 | +15 | +0.7% | 122,100 |
2025/03/21 | 2,271 | 2,298 | 2,271 | 2,285 | +17 | +0.7% | 89,300 |
2025/03/19 | 2,252 | 2,289 | 2,252 | 2,268 | +15 | +0.7% | 47,200 |
2025/03/18 | 2,258 | 2,272 | 2,245 | 2,253 | -4 | -0.2% | 45,100 |
2025/03/17 | 2,236 | 2,261 | 2,235 | 2,257 | +22 | +1% | 52,400 |
2025/03/14 | 2,256 | 2,265 | 2,235 | 2,235 | -25 | -1.1% | 63,400 |
2025/03/13 | 2,241 | 2,267 | 2,234 | 2,260 | +13 | +0.6% | 76,300 |
2025/03/12 | 2,208 | 2,257 | 2,193 | 2,247 | +55 | +2.5% | 127,300 |
2025/03/11 | 2,195 | 2,208 | 2,167 | 2,192 | +9 | +0.4% | 66,300 |
2025/03/10 | 2,216 | 2,220 | 2,166 | 2,183 | -23 | -1% | 113,500 |
51~
100
件表示中 / 3754件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 211,700円 | +3.1% | -6.5% | 2.27% | 9.82倍 | 1.04倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ジーエヌアイ | 279,200円 | +21.7% | +999.9% | 0.00% | 11.71倍 | 3.87倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 323,000円 | +5.1% | -7.0% | 2.48% | 21.20倍 | 0.88倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
杏林製薬 | 154,300円 | -2.4% | -52.3% | 3.69% | 18.47倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 223,600円 | +4.1% | -3.1% | 2.59% | 19.42倍 | 1.69倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム